CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 86 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,086,522 | -46.3% | 49,772 | -21.8% | 0.00% | -100.0% |
| Q2 2023 | $2,022,767 | +36.2% | 63,629 | +4.5% | 0.00% | – |
| Q1 2023 | $1,484,619 | +195.7% | 60,870 | +282.4% | 0.00% | – |
| Q4 2022 | $501,991 | +780.7% | 15,916 | +691.4% | 0.00% | – |
| Q3 2022 | $57,000 | -6.6% | 2,011 | -12.3% | 0.00% | – |
| Q2 2022 | $61,000 | -82.0% | 2,294 | -76.3% | 0.00% | – |
| Q1 2022 | $339,000 | -55.5% | 9,688 | -58.7% | 0.00% | – |
| Q4 2021 | $761,000 | -45.0% | 23,481 | -49.9% | 0.00% | – |
| Q3 2021 | $1,383,000 | – | 46,869 | +4686800.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 1 | -99.6% | 0.00% | – |
| Q4 2020 | $4,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,005,284,000 | 38.09% |
| Ally Bridge Group (NY) LLC | 1,767,440 | $29,304,000 | 5.02% |
| Affinity Asset Advisors, LLC | 270,000 | $4,477,000 | 2.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 811,665 | $13,457,000 | 1.19% |
| Artal Group S.A. | 2,282,100 | $37,837,000 | 0.81% |
| Perceptive Advisors | 4,544,062 | $75,340,000 | 0.81% |
| RA Capital Management | 2,200,000 | $36,476,000 | 0.51% |
| Monashee Investment Management LLC | 200,000 | $3,316,000 | 0.44% |
| Boxer Capital, LLC | 714,500 | $11,846,000 | 0.38% |
| EcoR1 Capital, LLC | 400,000 | $6,632,000 | 0.36% |